Modifying Toll-like Receptor 9 Signaling for Therapeutic Use

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|6|3|287-291

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.6, Iss.3, 2006-03, pp. : 287-291

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adaptors in Toll-Like Receptor Signaling and their Potential as Therapeutic Targets

By  

Current Drug Targets, Vol. 13, Iss. 11, 2012-01 ,pp. : 1360-1374

Bentham Science Publishers

Access to resources Recommend Favorite

Toll-like receptor 9 agonists as cancer therapeutics

By Holtick Udo   Scheulen Max E   von Bergwelt-Baildon Michael S   Weihrauch Martin R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 361-372

Informa Healthcare

Access to resources Recommend Favorite

Toll-Like Receptor Signaling Mechanisms Involved in Dendritic Cell Activation: Potential Therapeutic Control of T Cell Polarization

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-11 ,pp. : 4247-4254

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

By Gupta Kaveri  

Drugs in R&D, Vol. 9, Iss. 3, 2008-01 ,pp. : 137-145

Adis International

Access to resources Recommend Favorite

Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 24, Iss. 17, 2018-05 ,pp. : 1887-1898

Bentham Science Publishers

Access to resources Recommend Favorite